Vigna Law Group: Missed Spinal Cord Injuries…How and Why

Dr. Greg Vigna

Dr. Greg Vigna

Dr. Greg Vigna comments on hospitals' failure to diagnose spinal cord injuries, leading to catastrophic repercussions for the patient.

Nurses, physical therapists, and occupational therapists must sound the alarm when physicians make diagnostic errors, and most of the time the errors are obvious.”

— Dr. Greg Vigna

SANTA BARBARA, CALIFORNIA, UNITES STATES, December 4, 2020 /EINPresswire.com/ — “Approximately 50% of patients who sustained a spinal cord injury that were misdiagnosed by hospital personnel will result in neurological deterioration.” – Greg Vigna, MD, JD

The primary reasons for a failure to diagnose a spinal cord injury cited in the literature include the following:

1) Missed radiographic findings on X-ray and CT scan,
2) Impair cognition of injured because of intoxication, brain injury, or other serious injuries,
3) Improper removal of cervical collars without a reasonable exam or diagnostic imaging, and
4) Failure to provide a careful physical exam and functional exam.

A study from England revealed that the average delay in diagnosis of a spinal cord injury from initial presentation to medical professionals was four days and rarely was the failure to diagnose caused by one failure but resulted from a failure across multiple providers including EMT (emergency medical transportation personnel), triage nurses, emergency room physicians, neurosurgeons, orthopedic surgeons, physical therapist, occupational therapist, and nurses.

Dr. Greg Vigna, spinal cord injury physician, national pharmaceutical injury attorney, national neurological injury attorney, and Certified Life Care Planner states, “Missed spinal cord injuries rarely are caused by one error but multiple failures where medical professionals are not applying independent professional judgment. Unfortunately, we are seeing hospitals cutting costs to increase profits by moving to models that have nurse practitioners and physician assistants doing much of the work in emergency rooms and on the medicine/surgical floors so patient-physician contact is limited to a few brief encounters.”

Dr. Vigna adds, “Missed spinal cord injuries do occur in cases where there are multiple serious injuries, and a patient is unresponsive but should never happen in a patient who is alert, oriented, and can participate in a meaningful physical exam that is combined with walking and other functional tasks such as dressing, toileting, and activities of daily living. Nurses, physical therapists, and occupational therapists must sound the alarm when physicians make diagnostic errors, and most of the time the errors are obvious.”

Dr. Vigna concludes, “My attorney team understands that failure to timely diagnose a spinal cord injury that results in neurological deterioration is a much stronger better case than those who have suffered adverse outcomes during surgical treatments. But given the severe disability and cost of future care, every spinal cord injury should be evaluated by a spinal cord injury attorney to look at the medical care provided and the circumstances related to the injury as defective products such as car tires, defective roads, and numerous other factors may have contributed to the cause of injury which may bring in defendants with sufficient insurances that may provide necessary financial relief for the injured.”

Greg Vigna, MD, JD, is a California and Washington DC lawyer who focuses on catastrophic neurological injuries cause by the vaginal mesh, brain injuries, spinal cord injuries, brachial plexus injuries, and medical malpractice. He is Board Certified in Physical Medicine and Rehabilitation.
The Vigna Law Group is a national neurological injury law firm and national pharmaceutical injury law firm that co-counsels with leading trial attorneys across the country to achieve justice.

Click here for a FREE BOOK on Pelvic Mesh Pain.

References:
https://cache1.medsci.cn/webeditor/uploadfile/201307/20130702100109927.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348314/

Greg Vigna, MD, JD
Vigna Law Group
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Bone Grafts and Substitutes Market Growing at 4.8% CAGR to Reach $3,912 Million by 2025

Bone Grafts and Substitutes

Bone Grafts and Substitutes

Rise in preference for biocompatible bone grafts are the key factors that contribute toward the growth of the bone grafts & substitutes market

Bone Grafts & Substitutes Market to Reach $3.91 Bn by 2025 Rise in preference for biocompatible bone grafts are the key factor that contribute toward the growth of the bone grafts & substitutes market”

— Ashish

PUNE, MAHARASHTRA, UNITED STATES, December 4, 2020 /EINPresswire.com/ — The global bone grafts and substitutes market was valued at $2,690 million in 2017, and is expected to reach $3,912 million by 2025, registering a CAGR of 4.8% during the forecast period. Bone grafts are implantable materials that promote bone healing, bone formation, and osseous reconstruction.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1774

Rapid development of novel bone grafts materials such as biocompatible synthetic bone grafts and rise in prevalence of bone and joint disorders are the major factors driving the growth of the global bone grafts and substitutes market. Moreover, surge in the number of patients suffering from rheumatoid arthritis, osteoarthritis, and other joint disorders have supplemented the market growth. However, high cost of surgeries and several ethical issues associated with bone grafting procedures have hampered the market development. On the contrary, increasing inclination of key market players toward R&D activities and surge in demand for orthopedic procedures among geriatric population would provide lucrative opportunities for the market leaders in the coming years.

The use of bone grafts and substitutes reduces the need to harvest autograft bones from patients, which in turn reduces postoperative pain and healing time. Increased use of bone graft substitutes facilitates minimally invasive surgeries and short surgical procedures. Although these procedures were initially used for spinal fusion and rectification of deformities, the adoption of these procedures has increased for various applications, including extremity reconstruction and treatment of fractures.

The report segments the global bone grafts and substitutes market by type, application, and geography. Based on the type, the report categorizes the market into allograft, bone graft substitutes, and cell-based matrices. An increase in the prevalence of bone and joint disorders have garnered the bone graft substitutes segment to generate maximum revenue in 2016. The segment is expected to dominate the global market through 2025, owing to advancements in bone graft materials and the development of innovative products. However, cell-based matrices (CBM) segment is expected to grow at the highest rate, a CAGR of 6.1%, during the forecast period, as these materials serve as a cell-based bone grafts substitutes that use cells to generate tissue alone or in combination with support matrix.

For Purchase Enquiry:https://www.alliedmarketresearch.com/purchase-enquiry/1774

Key Findings of the Bone Grafts and Substitutes Market:

Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2017, and is expected to continue to lead the during the forecast period.

Asia-Pacific is expected to witness highest market growth rate, with a CAGR of 7.3% from 2018-2025

U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%.

Cell based matrices (CBM) is projected to grow at the highest CAGR of 6.1% from 2018 to 2025, as these materials serve as a cell-based bone grafts substitutes that use cells to generate tissue alone or in combination with support matrix. In addition, the advantages offered by CBM such as reproducibility and cost-effectiveness have fueled the market growth.

North America held the dominant position in the global market in 2017, and is expected to maintain its lead throughout the analysis period. This is attributed to rise in incidence of spinal fusion & joint reconstruction procedures, sedentary lifestyle contributing to joint disorders in the geriatric & younger population, and favorable reimbursement rates in the region.

Access Full Report: https://www.alliedmarketresearch.com/bone-graft-substitutes-market

The key players profiled in this report include:

Arthrex, Inc.
Baxter International Inc.
Integra LifeSciences Holdings Corporation
Johnson & Johnson (DePuy Synthes)
Medtronic Plc.
Musculoskeletal Transplant Foundation
NuVasive, Inc.
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings, Inc.

Similar Report with Detailed COVID-19 Impact Analysis:

Orthopedic Devices Market Global Opportunity and Industry Forecast, 2026

Meningococcal Vaccine Market Global Opportunity and Industry Forecast, 2026

Hernia Repair Devices and Consumables Market Opportunity Analysis 2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada): +1-800-792-5285, +1-503-446-1141
International: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Ashish Gujrathi
Allied Market Research
+1 9049962983
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

PsyTech Inc. Chooses ilumivu’s SaaS Platform to Power its Groundbreaking New Clinical Software

Hayim Raclaw, PsyTech CEO

By equipping therapists with unprecedentedly rich data for constant improvement, this partnership will accelerate innovation for psychedelic therapeutics, enabling better and safer patient care. ”

— Hayim Raclaw

TORONTO, ON, CANADA, December 4, 2020 /EINPresswire.com/ — PsyTech Inc., a leading company advancing psychedelic medicine, announced today the signing of an exclusive agreement with a Digital Therapeutics SaaS platform for mental and behavioral health from ilumivu to create its Psychedelic-Assisted Therapy (PAT) clinical solution under the brand Tovana.

PsyTech is launching Tovana Solutions — the most comprehensive mobile and web application for PAT therapists and patients around the world. The platform’s features will include cutting edge just-in-time-adaptive-interventions (JITAI), biometric data capture and 3rd party device integration, whereby therapists can use the application along with patients served by healthcare clinics utilizing psychedelic-assisted therapies to enable increased treatment efficacy and improved patient outcomes.

After ruling out costly development and a review of commercially available products, PsyTech chose ilumivu’s SaaS platform given that company’s exceptional clinical and research experience, feature-rich technology, and proven status as a platform serving leading global medical research organizations. The two companies aim to onboard hundreds of PAT-inclusive clinics and retreat centers, powering the most effective therapeutic organizations in the industry.

PsyTech CEO Hayim Raclaw said, "By equipping therapists with unprecedentedly rich data for constant improvement, this partnership will accelerate innovation for psychedelic therapeutics, enabling better and safer patient experience and access. Our two companies are powerfully complementary in terms of business strengths and simpatico in terms of ethos and people. We are excited for this future."

The companies plan to roll out the initial ilumivu-powered Tovana Solutions to clinics in the United State in the first phase. In phase two, they will broaden market availability through expansion in the US and rollout to Canada, Israel, and the EU. The application will become generally available worldwide. PsyTech is planning to bring the application to PAT-inclusive clinics across the globe over the next two to three years.

“This platform partnership with PsyTech fits ilumivu’s market strategy perfectly. We are bringing the power of our SaaS platform to existing and new emerging players in multiple specialties within healthcare to create life-changing high value applications in autism, chronic disease management, PTSD/stress solutions, doctor-patient engagement, medical cannabis, and mental and behavior health,” said David Smith, ilumivu’s president.

About PsyTech
Venture-backed PsyTech combines a robust psychedelic therapeutic community with clinical tools and integrative mental health. Its chief goals are to promote and deliver safe and effective psychedelic health and wellness, combat stigma, and accelerate innovation. Empowered by the advancements of ground-breaking clinical research, PsyTech fosters and steers innovation in psychedelics to serve the greater good.

About ilumivu
ilumivu is a Digital Therapeutics company enabling proactive interventions and delivering personalized outcomes using the psychology of behavior change. Our platform connects patients and clinicians enabling therapists, case workers, researchers, clinicians and hospitals to better monitor, manage, and direct the patient/individual care. We increase adherence, impact positive behavior changes and provide a pinpoint assessment of the patient journey based on our real-time data capture and analysis algorithms.

Mike Maloney
Right Hook Public Relations
email us here


Source: EIN Presswire

Vaccine Market How Top Leading Companies Can Make This Smart Strategy Work

Vaccine

Vaccine

Vaccine Market is reach $54,150 million by 2027, CAGR of 6.6%. Asia-Pacific presents lucrative opportunities for the key players operating in the vaccine market

Vaccine Market is reach $54,150 million by 2027, Rise in immunization programs worldwide is one of the major factors that boost the growth of the vaccine market.”

— Ashish

PUNE, MAHARASHTRA, UNITED STATES, December 4, 2020 /EINPresswire.com/ — The vaccine market size accounted for $32.46 billion in 2019, and is expected to reach $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. High prevalence of diseases worldwide, surge in government focus towards immunization programs, and the emergence of technologically advanced vaccines drive the growth of the global vaccines market. Additionally, the prospect of high growth in emerging economies provides lucrative opportunities for emerging market players. However, high duration for vaccine production and high cost associated with it impede market growth.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/258

Most of the markets are dropping down, owing to the outbreak, including the vaccine market. The global vaccine market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, most of the leading companies across the globe have slow down the manufacturing of other vaccines. Furthermore, the individual contributions companies are collaborating to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19.

Rise in immunization programs worldwide is one of the major factors that boost the growth of the vaccine market. In addition, factors such as surge in awareness related to the use of vaccines and increase in adoption of vaccination across the globe fuel the growth of the vaccine market. However, high monetary inputs associated with manufacture of the products restrains the growth of the market. On the contrary, growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

Key Findings Of The Study

The study provides an in-depth analysis, current trends, and future estimations of the global vaccine market to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict the vaccine market growth is provided.

It provides an extensive analysis of key segments to understand the type of products and indications used globally.

Extensive analyses of key segments of the industry help understand the types of products and technologies used across various geographies.

Inquire for Purchase Report: @ https://www.alliedmarketresearch.com/purchase-enquiry/258

Most of the markets are dropping down, owing to the outbreak, including the vaccine market. The global vaccine market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, most of the leading companies across the globe have slow down the manufacturing of other vaccines. Furthermore, the individual contributions companies are collaborating to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19.

Based on indication, the market is categorized into Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Diphtheria, Pertussis, & Tetanus (DTP), Polio, Hepatitis, Measles, Mumps, & Rubella (MMR), and Other Indications. The pneumococcal disease segment is expected to maintain its dominance during the forecast period, owing to the fact that Streptococcus pneumoniae (a pathogenic bacteria) is the leading cause of infectious diseases globally. However, human papilloma virus (HPV) segment is growing at the highest CAGR of 6.6% from 2020 to 2027, as it is the most common type of sexually transmitted disease, specifically in women, which causes cervical cancer, the fourth most common type of cancer prevailing in women.

Access Full Report: https://www.alliedmarketresearch.com/vaccines-market

The global vaccine market is segmented on the basis of technology, indication, end user, and region. Depending on technology, the market is classified into recombinant & conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines, and others. By indication, the market is classified into pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella, diphtheria, pertussis & tetanus (DPT), polio, hepatitis, measles, mumps, & rubella (MMR) and other Indications. According to end user, the market is segmented into pediatric, adults, and travelers.

The key players operating in the vaccine market:

Serum Institute of India Pvt. Ltd.
Pfizer
Johnson & Johnson
AstraZenecea plc
GlaxoSmithKline plc
Sanofi Aventis
Merck & Co., Inc.
Emergent BioSolutions Inc.
CSL Limited
Novavax, Inc.

Similar Report with Detailed COVID-19 Impact Analysis:

Cancer Biomarkers Market

Epigenetics Market

Middle East Disposable Gloves Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada): +1-800-792-5285, +1-503-446-1141
International: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

David Correa
Allied Analytics LLP
+19049962983 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Heidi Jandel Weiland of Vibrant Living to be Featured on Close Up Radio

ANCHORAGE, ALASKA, UNITED STATES, December 4, 2020 /EINPresswire.com/ — Holistic life coach Heidi Jandel Weiland believes that when women find themselves stuck in their life, and they decide to do something about it, it can be the beginning of a journey beyond their wildest dreams.

Heidi is the founder of Vibrant Living, where she helps introverted women who are unhappy with their lives get unstuck, build lasting self-confidence and feel more at peace.

“Many of us live not so vibrantly,” says Heidi. “Often it’s not for lack of information. In fact, when my clients first come to me, they’re usually feeling deeply overwhelmed, anxious and frustrated with their lives because they think they know what it takes to live vibrantly but they just can’t seem to make it happen. They think the problem is because of their job or their husband or their laziness or something else, but it’s almost always about self-doubt.”

Most of Heidi’s work, she says, revolves around helping her clients reduce anxiety and build self-confidence. Being a holistic life coach, she approaches this from a mind, body and spirit perspective.

“Self-confidence is a skill.” says Heidi. “When you can learn this skill, you can apply it anywhere in your life that you need it.”

The first step, says Heidi, is for her clients to become aware of the belief patterns that have created their current problems. Once they do this, they start to see how much power they actually have in their lives and it becomes easier to figure out how to make the changes they want so that they feel happier.

Of course, most coaches coach what they have experience with, and Heidi admits self-confidence was once a challenge for her, too. Prior to launching Vibrant Living, Heidi owned a web development company with great clients, great projects, great employees, but on the inside she was really unhappy and burned out.

“I was working from a place of such low self-confidence,” recalls Heidi. “I was overworked all the time because I didn't have boundaries. I wasn't taking care of myself and always put other people first. When that goes on year after year, and you build your company based on that, it eventually gets to a point where something has to change.”

“So I started investing in myself by studying yoga and Ayurveda. Then I started working with a life coach and she helped me to finally decide to let go of that old business and take a leap into the unknown. I had no idea I was going to become a coach. It evolved as I kept moving forward and opened myself to new possibilities and really started to believe in myself more.”

Heidi says her mission is one of hope and empowerment.

“I've always been a helper. I've always enjoyed supporting people and I love personal growth. It feels like just this natural extension of who I am, my life’s purpose. I just love seeing people transform and tap into their own sense of power and possibility to make changes in their lives.”

Close Up Radio will feature Heidi Jandel Weiland in an interview with Jim Masters on December 8th at 12pm EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information, visit www.heidijandel.com

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Impfungen bei Krebs – das Immunsystem aktiv stärken

Neue Online-Schulung zum aktuellen Thema Impfen ab jetzt kostenlos auf selpers.com verfügbar

VIENNA, AUSTRIA, December 4, 2020 /EINPresswire.com/ — "Bei der Diagnose einer Krebserkrankung ist es wichtig, dass Arzt und auch Patient Impfungen als ganz bedeutenden Bestandteil vom Gesamtbehandlungskonzept erkennen“, bringt es Univ.-Prof.in Dr.in Ursula Wiedermann-Schmidt auf den Punkt. In einer Online-Schulung zum Thema „Impfungen bei Krebs“ auf selpers.com räumt die Expertin mit unbegründeten Ängsten auf, gibt klare Antworten auf die häufigsten Fragen zum Thema und liefert zahlreiche praktische Tipps – vom richtigen Impfzeitpunkt bis hin zur Kostenrückerstattung.

Die Bedeutung eines individuellen Impfplanes bei KrebspatientInnen wird nach wie vor unterschätzt. Viele Betroffene haben Angst vor Impfungen, da sie fürchten, ihr Immunsystem zusätzlich zu schwächen. Doch wie man heute weiß, ist genau das Gegenteil der Fall: Impfungen sind bei Krebserkrankungen sogar sehr hilfreich. Das durch die Krebserkrankung und die Therapien beanspruchte Immunsystem kann durch den richtigen Impfplan wieder aktiv werden, sich koordiniert gegen Infektionskrankheiten schützen und somit auch die Abwehr gegen den Krebs besser in Angriff nehmen.Dieses Wissen über die Vorteile von Impfungen bei einer Krebsdiagnose leicht verständlich an PatientInnen und Angehörigen weiterzugeben, ist das Ziel der neuen Online-Schulung, die ab sofort kostenlos und ganz ohne Anmeldung aufrufbar ist. Damit Infektionskrankheiten erst gar keine Chance haben.

Initiatorin der neuen Schulung ist Elfi Jirsa, ihres Zeichens Präsidentin der Myelom- und Lymphomhilfe Österreich, die aus aktuellem Anlass gemeinsam mit selpers, der Plattform für chronisch Kranke und Angehörige, und Univ.-Prof.in Dr.in Ursula Wiedermann-Schmidt, Fachärztin für Immunologie, spezifische Prophylaxe und Tropenhygiene, das Thema umgesetzt hat. Wiedermann-Schmidt gibt in der 96-minütigen Online-Schulung KrebspatientInnen und Angehörigen ein wichtiges Werkzeug zur Bewusstseinsbildung und Entscheidungshilfe in die Hand.

Expertin antwortet auf Impf-FAQs
„Gerade jetzt, da die Influenza-Impfung – eine der wichtigsten Impfungen für Krebspatientinnen – optimaler Weise geimpft wird, ist eine professionelle, umfangreiche Beratung für Krebspatienten wichtig,“ unterstreicht Jirsa die Bedeutung des kostenlosen Angebotes „Und bei Ursula Wiedermann-Schmidt sind die PatientInnen in den besten Händen.“

Wiedermann-Schmidt leitet an der Medizinischen Universität Wien eine Spezialambulanz, die sich an chronisch kranke PatientInnen richtet. Gerade bei einer Krebsdiagnose tauchen etliche Fragen rund um die gesundheitliche Vorsorge auf, die in der Online-Schulung mittels Kapitelmarker ganz gezielt gefunden werden können: Was darf während einer Krebstherapie geimpft werden? Wer kann mir bei der Refundierung der Impfstoffkosten helfen? Sollten auch meine Angehörigen und Freunde ihren Impfstatus überprüfen? Kann ich mich während der Chemotherapie gegen Influenza impfen lassen?

Immunstatus in Ordnung bringen & Abwehr aktiv stärken
In der Onkologie hat die personalisierte Medizin bereits Einzug genommen und ebenso müssen auch Impfschemata für KrebspatientInnen individuell adaptiert werden. „Meine zentrale Botschaft an alle KrebspatientInnen lautet, dass es ganz wichtig ist, zu wissen, dass Impfungen zum Gesamtbehandlungskonzept dazu gehören. Meistens ist eine Krebserkrankung wie eine chronische Erkrankung: Sie ist Teil des Lebens, das natürlich Veränderungen erfahren hat, aber die Impfungen gehören weiterhin dazu, damit man auch in Bezug auf Infektionskrankheiten fit bleibt.“ unterstreicht Wiedermann-Schmidt. Das geschwächte Immunsystem sei besonders anfällig für Infektionskrankheiten und brauche besonderen Schutz. Bestenfalls sollte bereits bei Diagnosestellung der Impfstatus überprüft und der Immunstatus noch vor Therapiebeginn in einen guten Zustand gebracht werden.

„Es ist die Einstellung dazu, das Bewusstsein und das Wissen, dass Impfungen so ein wichtiger Teil sind.“

Die Online-Schulung für PatientInnen und Angehörige „Impfungen bei Krebs“ ist hier kostenlos und ohne Anmeldung abrufbar: https://selpers.com/kurs/impfungen-bei-krebs/

Phillipp Annerer
selpers og
+43 1 59540000
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Cannabidiol (CBD) Market 2020 Global Trends, Top players, Demand, Share, Segmentation and Forecast to 2026

Global Cannabidiol (CBD) Market Insights 2020

Wiseguyreports.Com Publish New Report On-“Covid-19 Impact on Cannabidiol (CBD) Market 2020 Global Analysis, Size, Share, Trends, Opportunities and Growth 2026”

PUNE, MAHARASTRA, INDIA, December 4, 2020 /EINPresswire.com/ —

Cannabidiol (CBD) Market 2020

Global Cannabidiol (CBD) Scope and Market Size

The global Cannabidiol (CBD) market has a higher potential for dealing with the business needs of several industries and organizations. They have products listed under their market to give enhanced functionality to the industries to help them earn their profitable outcome. The products listed under the market are highly efficient in terms of technology integration and materials used. Hence, these products developed by the key players are highly efficient and are tagged at affordable pricing to help small and large scale industries afford it. The potential of the global Cannabidiol (CBD) market is increasing with every passing day as more consumers are turning up for availing the products.

The top players covered in Cannabidiol (CBD) Market are:

CBD American Shaman
ENDOCA
Gaia Botanicals
Isodiol
Medical Marijuana
Aurora Cannabis (AC)
Cannoid
Canopy Growth Corporation
CV Sciences
IRIE CBD
Elixinol
NuLeaf Naturals
PharmaHemp
Folium Biosciences

Get Free Sample Report @ https://www.wiseguyreports.com/sample-request/5857834-global-cannabidiol-cbd-market-insights-2020-by-top

Cannabidiol (CBD) Market Risks and Drivers

The key players have the potential to manufacture the products at a higher pace by developing or upgrading the infrastructure. Along with that, they also handle the promotion of the products to sell it to a greater number of targeted consumers. Moreover, the key players also evolve the technology embedded within the products to make it more efficient and productive. As a result, the global Cannabidiol (CBD) market also thrives by increasing the sales count. The better the efficiency, the higher will be the sales count. The key players have the potential to discontinue old products and add new products to the list simultaneously to increase the sales count and demand requests for the global Cannabidiol (CBD) market.

The report estimates the growth opportunity of the Cannabidiol (CBD) market along with the potential of it to withstand the market fluctuations. There are many products that are requested on priority by the targeted consumers to make their businesses run smoothly in the long run for giving out productive results. Along with that, the report also highlights the regional classification to give insight into the market behaviour’s across different regions of the globe. The market revenue generated in the previous forecast period was higher than ever. As the demands have grown now, the market size is expected to rise even beyond the highest recorded figure in the current forecast period 2021 to 2026.

Regional Analysis of Cannabidiol (CBD) Market

The global Cannabidiol (CBD) market is popular across various regions of the globe that includes North America, South America, Europe, Asia-Pacific and rest of the world. The key players across different parts of the world are putting in their maximum efforts to make sure that the global Cannabidiol (CBD) market thrives. Amongst all the regions, North America has the highest demand for the products listed under the global Cannabidiol (CBD) market.

For Customisation and Query @ https://www.wiseguyreports.com/enquiry/5857834-global-cannabidiol-cbd-market-insights-2020-by-top

Table of Contents –Analysis of Key Points

1 Cannabidiol (CBD) Market Overview
2 Manufacturers Profiles
3 Global Cannabidiol (CBD) Sales, Revenue, Market Share and Competition by Manufacturer (2018-2019)
4 Global Cannabidiol (CBD) Market Analysis by Regions
5 North America Cannabidiol (CBD) by Country
6 Europe Cannabidiol (CBD) by Country
7 Asia-Pacific Cannabidiol (CBD) by Country
8 South America Cannabidiol (CBD) by Country
9 Middle East and Africa Cannabidiol (CBD) by Countries
10 Global Cannabidiol (CBD) Market Segment by Type
11 Global Cannabidiol (CBD) Market Segment by Application
12 Cannabidiol (CBD) Market Forecast (2020-2026)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
List of Tables and Figures

Continued…..

NORAH TRENT
Wise Guy Reports
+162 825 80070
email us here


Source: EIN Presswire

Investors of OrthoPediatrics With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C.

Securities Class Action Investigation On Behalf Of Shareholders Of OrthoPediatrics Corp.

NEW YORK, USA, December 4, 2020 /EINPresswire.com/ — Kehoe Law Firm, P.C. is investigating claims on behalf of investors of OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Culper Research published a report, “OrthoPediatrics Corp. (KIDS): Even Channel Stuffing Can’t Save This Company,” which, among other things, stated that Culper Research “. . . believe[s] OrthoPediatrics has engaged in a channel stuffing scheme that has systematically and significantly overstated revenues.”

On this news, the stock price of OrthoPediatrics fell $4.12 per share, or 9.13%, to close at $41.02 per share on December 2, 2020.

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE SECURITIES OF ORTHOPEDIATRICS AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.

Michael Yarnoff, Esq.
Kehoe Law Firm, P.C.
+12157926676
info@kehoelawfirm.com


Source: EIN Presswire

Operating Room Integration Market Expected to Reach $4,195.9 Million by 2027

Operating Room Integration Market

Operating Room Integration Market

The leading players are investing in R&D in developing advanced display technologies that can be connected over Video IP solutions.

PUNE, MAHARASHTRA, INDIA, December 4, 2020 /EINPresswire.com/ — Ease in visualization of patient monitoring and display solutions, advancement of display technologies such as miniaturization of display and ultra-high-quality display outputs drive the market for display solutions for operating room integration. Further, latest technologies provide various modes of display such as mirror image mode, picture-in-picture mode, and side-by-side flexible for multi-image viewing mode. This increases the demand for display solutions among doctors.

The remote and ease of control for video output, high quality display technologies, multiple video screens streaming on one display, and share of videos between different operating room increase the demand for video over IP solutions. Further, the launch of latest A/V streaming devices over IP solutions for digital operating rooms drives the operating room integration market growth. For instance, Sigma-XG which is a one product and one cable infrastructure, which means the device uses only one cable for connection throughout the building it is installed in and can be used to stream video in multiple operating rooms. Therefore, these advancement in audio and video management system drives the operating room integration market growth.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/4004

The global operating room integration market size was valued at $1.77 Billion in 2019, which is projected to reach $4.19 Billion by 2027, growing at a CAGR of 11.4% from 2020 to 2027.

The factors such as advancement in surgical procedures, surge in patient preference for minimally invasive surgeries, and patient monitoring to provide safety boost the growth of the market. However, high initial investment and maintenance of ORI systems hampers the growth of the market. On the contrary, untapped potential of emerging markets are expected to offer lucrative opportunities for the growth of the market globally.

Access Full Report: https://www.alliedmarketresearch.com/operating-room-integration-market

Region wise, the market is analyzed across North America, EMEA, China, and Asia-Pacific. North America was the highest revenue generator in 2019, accounting for $790.0 million, and is estimated to garner $1,622.1 million by 2027, growing at a CAGR of 9.5%.

The global operating room integration market is segmented on the basis of device type, application, end user, and region. Based on the device type, the market is divided into audio & video management system, display system, documentation and recording system, and others. Further, audio & video management system segment is classified into simple video management, advanced video management, and data comparing IP-based version. In addition, display system is categorized into small display and large format display.

Enquire For More: https://www.alliedmarketresearch.com/purchase-enquiry/4004

The key players operating in the operating room integration market include Stryker Corporation, KARL STORZ GmbH & Co. KG, STERIS plc, Skytron LLC, Getinge AB, Merivaara Oy, Canon Inc., BrainLab AG, Doricon Medical Systems, and Olympus Corporation, which are profiled in this report. The key market players adopt various strategies such as product launch, product development, collaboration, partnership, agreements, among others to influence the market growth.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Clinician, Author, Food Critic Nicki Pendleton Wood Joins Healthcare Marketing Agency fuoco as Managing Editor

Nicki Pendleton Wood, fuoco managing editor

Wood to lead client content strategy and development

Nicki is an extremely skilled and talented writer, editor and creative thinker and a huge asset for us and our clients across all media.”

— Kriste Goad, fuoco founder and chief fire starter

NASHVILLE, TN, UNITED STATES, December 4, 2020 /EINPresswire.com/ — Healthcare marketing and communications agency fuoco today announced the addition of Nicki Pendleton Wood as Managing Editor, a new role created to guide and grow the agency’s content team in the development of best-in-class editorial, creative and thought leadership content for clients.

“Nicki is an extremely skilled and talented writer, editor and creative thinker and a huge asset for us and our clients across all media,” said Kriste Goad, fuoco founder and chief fire starter. “Stand-out content has never been more important to our clients in the pursuit of driving trust, awareness, thought leadership and engagement with their brands. We’re thrilled to welcome Nicki to the team and confident that her expertise in healthcare, food and media will broaden our capabilities in countless ways, including the growing ‘food-as-medicine’ movement and its place among social determinants of health, which has been made even more clear in the wake and midst of the COVID-19 pandemic.”

With a diverse background ranging from food writer, copy editor and cookbook writer to mammographer, clinician and healthcare analyst, Wood brings a unique combination of skills to fuoco where she will oversee the agency’s writing, editing and content strategy work to help build and grow its content team and expand its client base. She will be responsible for strategizing with clients as subject matter experts and with client teams to create content that advances marketing and communications goals and initiatives, and successfully drives ROI.

“I’m excited to leverage the skills I’ve developed over the years, both in writing and in healthcare, to do good work that’s meaningful – fuoco’s mission – and help clients succeed through next-level content strategy and development,” Wood said. “I previously had the pleasure of leading writing workshops for the fuoco staff and was astonished by the amount of great content they were pushing out for clients. Now I get to be a part of the bigger picture, which will be super impactful from a strategy standpoint.”

A Nashville native, Wood is a veteran of newspapers, publishing, healthcare and healthcare technology. She has been an active freelancer, which led her to a four-year stint as the food blogger and restaurant reviewer for the Nashville Scene weekly newspaper while she attended radiology tech school. She worked as a mammographer and staff clinician at Lifesigns Health, a small clinic, then moved to Healthstream, where she was a content and metadata analyst and quality assurance analyst.

Wood’s earlier experience includes working in News and Public Affairs at Vanderbilt University, at Nashville Banner and Nashville Post newspapers, and cookbook publisher FRPBooks. She also taught writing in Cambridge, England, and in Nashville at Watkins College of Art and Design. Wood has ghost-written or guest-written several cookbooks and has one of her own titled Southern Cooking for Company (HarperCollins, 2015).

Wood attended Southern Methodist University and graduated from Sewanee, the University of the South, where she earned her bachelor’s degree in English literature with a minor in art history. She earned her master’s degree in English from University of North Carolina at Chapel Hill. Wood also graduated from the radiologic technology program at Nashville General Hospital and is qualified as a mammographer.

Wood started her new role at fuoco in late October.

About fuoco
fuoco is a Nashville-based marketing and communications agency focused on healthcare, technology, exceptional results, and doing good work that’s meaningful. Founded in 2017, fuoco brings deep healthcare B2B knowledge and experience, sophisticated and strategic thinking and a figure-it-out mentality to every client engagement. We back our work with The BF DiffTM — our “before fuoco” guarantee that clients will experience a marketable difference within 90 days of joining forces. fuoco is located in The Shop at 1020, an Opportunity Zone coworking space for healthcare-focused startups and creative businesses. Visit growwithfuoco.com.

###

Madeline Abrams
fuoco
+1 847-337-8891
madeline@growwithfuoco.com
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire